In article <ralph.1151071575B at 128.196.137.12>, ralph at ccit.arizona.edu (Ralph M
Bernstein) writes:
> you were not discussing immunology in your diatribuic discourse, but
>teleology. that is what i pointed out.
That would seem to be the nature of threads.
>yes indeed i have many a comment,
>but this issues will not be solved by this teleological verbiage, but by
>experiments-and that is what i do, on this subject. i may not have the
>insight that you and chris have, but i work at it and contribute my part. i
>pointed out that your discussion was seemingly going no where. indeed
>discussion is involved: einstein, although, formulated his theory, and that
>prompted one of the largest explosions in theoretical knowledge ever in
>relativistic physics-his theories were later, and are still, being proven,
>both correct and incorrect, today. usually, if really involved in a
>scientific discussion, a person wouldnt respond so defensively? so, indeed
>if your high moral platitude is appreciated out there, i will cease any
>further remarks. and thank you for pointing out the veritable definition of
>a theory to me.
> and if you had been reading this thread when it appeared you would have
>seen my comments that both applauded the "new" theory, and cautioned its
>acceptance as a new theory, but as a melding of several already present for
>some time.
Ok, first, if you would like to share your ideas you are more than welcome (no
POV is better/more-or-less important than any other here). Second, papers are
generally more restricted in the type of discussion allowed than a newsgroup.
This form of comunication often leaves the original topic without very much
restriction. If you do not like the topic in a thread you can reply further
back the tree or just make a new topic.
> (i would have normally emailed personally to a response such as this,
>but since he posted his response, fairs?)
As long as you are not attacking an individual, but rather an idea, concept, or
statement it is preferable to post to the group (that is afterall the point).
Chris Thoburn
